BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lovett GC, Nguyen T, Iser DM, Holmes JA, Chen R, Demediuk B, Shaw G, Bell SJ, Desmond PV, Thompson AJ. Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience. World J Hepatol 2017; 9(1): 48-56 [PMID: 28105258 DOI: 10.4254/wjh.v9.i1.48]
URL: https://www.wjgnet.com/1948-5182/full/v9/i1/48.htm
Number Citing Articles
1
Joel S. Emery, Jordan J. Feld. Treatment of hepatitis B virus with combination therapy now and in the futureBest Practice & Research Clinical Gastroenterology 2017; 31(3): 347 doi: 10.1016/j.bpg.2017.04.007
2
Jean Sehonou, Aboudou Raïmi Kpossou, Samuel Guido, Comlan N’dehougbea Martin Sokpon, Koffi Rodolph Vignon, Jacques Vigan. Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Patients Treated for Hepatitis B in the National University Hospital of CotonouOpen Journal of Gastroenterology 2018; 8(06): 213 doi: 10.4236/ojgas.2018.86024
3
Guo-Qing Yin, Jun Li, Bei Zhong, Yong-Fong Yang, Mao-Rong Wang. New therapeutic options for persistent low-level viremia in patients with chronic hepatitis B virus infection: Increase of entecavir dosageWorld Journal of Gastroenterology 2021; 27(8): 666-676 doi: 10.3748/wjg.v27.i8.666
4
Ittipat Meewan, Jiraporn Panmanee, Nopphon Petchyam, Pichaya Lertvilai. HBCVTr: an end-to-end transformer with a deep neural network hybrid model for anti-HBV and HCV activity predictor from SMILESScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-59933-4
5
Shahnaz Sali, Maryam Nasiri. Tenofovir Response Rate and Adverse Effects in Patients with Chronic Hepatitis B Attending to Hepatitis Clinic at Labbafinejad HospitalJundishapur Journal of Natural Pharmaceutical Products 2019; 14(3) doi: 10.5812/jjnpp.63023
6
Abdullah Bahnacy, Mabrouk Ghonaim, Esraa Mamdouh El Hosiny, Abdelnaser Abdelaty Gadallah. Occult Hepatitis (B) Infection in Hepatitis (C) Virus Infection Patients after the Treatment with Direct Acting Antiviral DrugsOpen Access Macedonian Journal of Medical Sciences 2022; 10(B): 2529 doi: 10.3889/oamjms.2022.7799
7
José Ángel Cuenca-Gómez, Ana Belén Lozano-Serrano, María Teresa Cabezas-Fernández, Manuel Jesús Soriano-Pérez, José Vázquez-Villegas, Matías Estévez-Escobar, Isabel Cabeza-Barrera, Joaquín Salas-Coronas. Chronic hepatitis B genotype E in African migrants: response to nucleos(t)ide treatment in real clinical practiceBMC Infectious Diseases 2018; 18(1) doi: 10.1186/s12879-018-3469-y
8
Long Jianfei, Li Ling, Zhang Yu, Zhang Jiming, Wang Bin. Tooth loss associated with the use of tenofovir disoproxil fumarateJournal of Clinical Pharmacy and Therapeutics 2020; 45(6): 1478 doi: 10.1111/jcpt.13219
9
Muhammad Sohaib Asghar, Muhammad Nadeem Ahsan, Uzma Rasheed, Maira Hassan, Rumael Jawed, Marium B Abbas, Rabail Yaseen, Syed Anosh Ali Naqvi, Hera Rizvi, Mashaal Syed. Severity of Non-B and Non-C Hepatitis Versus Hepatitis B and C Associated Chronic Liver Disease: A Retrospective, Observational, Comparative StudyCureus 2020;  doi: 10.7759/cureus.12294
10
Bingchen Ouyang, Fang Zhou, Le Zhen, Ying Peng, Jianguo Sun, Qianying Chen, Xiaoliang Jin, Guangji Wang, Jingwei Zhang. Simultaneous determination of tenofovir alafenamide and its active metabolites tenofovir and tenofovir diphosphate in HBV-infected hepatocyte with a sensitive LC–MS/MS methodJournal of Pharmaceutical and Biomedical Analysis 2017; 146: 147 doi: 10.1016/j.jpba.2017.08.028
11
Jie Luo, Xu You, Yutian Chong, Yuankai Wu, Jiao Gong, Yusheng Jie, Xinhua Li, Sujuan Xi, Zhiwei Zhang, Yufeng Zhang, Dongying Xie, Zhanyi Li, Xiangyong Li. Efficacy of long‑term treatment with tenofovir in Chinese nucleos(t)ide‑na�ve chronic hepatitis B patients regardless of baseline viral loadExperimental and Therapeutic Medicine 2019;  doi: 10.3892/etm.2019.7547
12
Pietro Lampertico, Thomas Berg, Maria Buti, Anita Pathil, Joerg Petersen, Stephen D. Ryder, Fabien Zoulim, Irina Botros, John F. Flaherty, Belinda Jump, Marjoleine L. Op den Brouw, Anna van Troostenburg, Heribert Ramroth. Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus‐infected patients with renal impairment: results from a 7‐year, multicentre retrospective cohort studyAlimentary Pharmacology & Therapeutics 2020; 52(3): 500 doi: 10.1111/apt.15901
13
Robert J. Wong, Ramsey C. Cheung. Real-World Safety and Effectiveness of Oral Nucleos(t)ide Analogs in the Treatment of Chronic Hepatitis B Virus InfectionCurrent Hepatology Reports 2021; 20(4): 144 doi: 10.1007/s11901-021-00571-z
14
Hannah Beck, Nishaanth Dalavaye, Kalaikshiga Kengadaran, Mosammath Monira Khatun, Ria Hitesh Patel, Taif Al-Rubaye, Laith Alrubaiy. Hepatitis B Management in the Middle East: A Narrative Review of Current Antiviral TreatmentsGastrointestinal Disorders 2024; 6(3): 784 doi: 10.3390/gidisord6030054
15
In Suk Min, Chang Hun Lee, Ik Sang Shin, Na Eun Lee, Hong Seon Son, Seung Bum Kim, Seung Young Seo, Seong Hun Kim, Sang Wook Kim, Seung Ok Lee, Soo Teik Lee, In Hee Kim. Treatment Outcome and Renal Safety of 3-Year Tenofovir Disoproxil Fumarate Therapy in Chronic Hepatitis B Patients with Preserved Glomerular Filtration RateGut and Liver 2019; 13(1): 93 doi: 10.5009/gnl18183
16
Eun-Hyung Yoo, Hyun-Jung Cho. Clinical response to long-term tenofovir monotherapy in Korean chronic hepatitis B patientsClinica Chimica Acta 2017; 471: 308 doi: 10.1016/j.cca.2017.06.019
17
Chantelli Iamblaudiot Razafindrazoto, Tovo Harimanana Rabenjanahary, Andry Lalaina Rinà Rakotozafindrabe, Sedera Radoniaina Rakotondrasoa, Nitah Harivony Randriamifidy, Anjaramalala Sitraka Rasolonjatovo, Soloniaina Hélio Razafimahefa, Rado Manitrala Ramanampamonjy, Haruki Komatsu. Effectiveness and Safety of Low Dose of Tenofovir Disoproxil Fumarate in Malagasy Patients with Chronic Hepatitis BBioMed Research International 2022; 2022: 1 doi: 10.1155/2022/1654620
18
Hong Thai, James Lara, Xiaojun Xu, Kathryn Kitrinos, Anuj Gaggar, Henry Lik Yuen Chan, Guo-liang Xia, Lilia Ganova-Raeva, Yury Khudyakov. Complex genetic encoding of the hepatitis B virus on-drug persistenceScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-72467-9
19
Jeanne Perino, Christine N. Adams. The Importance of Hepatitis B Antigen Screening in PregnancyNeonatal Network 2020; 39(6): 363 doi: 10.1891/0730-0832/11-T-657
20
Qian Zhang, Hong Peng, Xiaoqing Liu, Huimin Wang, Jinjie Du, Xinhua Luo, Hong Ren, Peng Hu. Chronic Hepatitis B Infection with Low Level Viremia Correlates with the Progression of the Liver DiseaseJournal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2021.00046
21
Vivek Chavda, Kelsee K. Zajac, Jenna Lynn Gunn, Pankti Balar, Avinash Khadela, Dixa Vaghela, Shruti Soni, Charles R. Ashby, Amit K. Tiwari. Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomesCancer Reports 2023; 6(S1) doi: 10.1002/cnr2.1821